As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
Secondly, on how good the intake ability of the individual is, considering stomach and gut health, toxic strain and/or increased need
Research indicates that this has implications for cognitive health as the peptide can pass the blood-brain barrier (1)
Most patients begin to notice changes in appetite within one to two weeks of their final injection, hunger returns, and food cravings (particularly for carbohydrate-rich foods) start to reassert themselves
Smith, C.J., Deutch, A.H
There's no one answer